University hospital North Norway
University hospital North Norway
Tromsø, Norway3 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Myocardial Infarction Safe Emergency Medicine Accompanying Study: Providing Reperfusion Therapy Within the Recommended Time Limits | Infarction, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, ischemic disease | Not yet recruiting | Not stated | 2025-07-30 | NCT07092904 | |
| Ocrelizumab VErsus Rituximab Off-Label at the Onset of Relapsing MS Disease | CNS demyelinating autoimmune disease, autoimmune disease, autoimmune disorder of the nervous system, demyelinating disease, immune system disorder, multiple sclerosis, nervous system disorder, relapsing-remitting multiple sclerosis | Active, not recruiting | Phase 3 | 2025-06-27 | NCT04578639 | |
| The Relapse from MRD Negativity As Indication for Treatment (REMNANT) Study | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Recruiting | Phase 2 / Phase 3 | 2025-03-20 | NCT04513639 |